CLVS

Clovis Oncology (CLVS)

Clovis Oncology Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:CLVS

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2023/05/02	05:17	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CLVS	Clovis Oncology Inc
2023/04/14	21:01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CLVS	Clovis Oncology Inc
2023/04/07	05:17	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CLVS	Clovis Oncology Inc
2023/03/02	22:02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CLVS	Clovis Oncology Inc
2023/02/17	06:32	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CLVS	Clovis Oncology Inc
2023/02/13	20:04	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CLVS	Clovis Oncology Inc
2023/02/10	23:49	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:CLVS	Clovis Oncology Inc
2023/01/12	20:16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CLVS	Clovis Oncology Inc
2022/12/29	23:36	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:CLVS	Clovis Oncology Inc
2022/12/13	20:10	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CLVS	Clovis Oncology Inc
2022/12/13	20:07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CLVS	Clovis Oncology Inc
2022/12/12	20:54	Dow Jones News	Clovis Oncology Shares Fall Premarket After Bankruptcy Filing	NASDAQ:CLVS	Clovis Oncology Inc
2022/12/12	14:18	Business Wire	Clovis Oncology Files for Chapter 11 Protection and Enters into Agreement to Sell FAP-2286	NASDAQ:CLVS	Clovis Oncology Inc
2022/11/17	06:16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CLVS	Clovis Oncology Inc
2022/11/09	22:12	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:CLVS	Clovis Oncology Inc
2022/11/04	05:18	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CLVS	Clovis Oncology Inc
2022/11/04	05:17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CLVS	Clovis Oncology Inc
2022/11/04	05:17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CLVS	Clovis Oncology Inc
2022/11/04	05:17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CLVS	Clovis Oncology Inc
2022/11/04	05:17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CLVS	Clovis Oncology Inc
2022/10/28	06:05	Business Wire	Clovis Oncology Presents Data from TRITON3 Phase 3 Trial of Rubraca® (rucaparib) at the 29th Annual Prostate Cancer Foundation Scientific Retreat	NASDAQ:CLVS	Clovis Oncology Inc
2022/10/17	16:45	Business Wire	Clovis Oncology Highlights Updated LuMIERE Phase 1 Data of Targeted Radiotherapy Candidate FAP-2286 at the 35th Annual EANM Congress	NASDAQ:CLVS	Clovis Oncology Inc
2022/10/05	05:17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CLVS	Clovis Oncology Inc
2022/10/03	20:00	Business Wire	TRITON3 Phase 3 Trial of Rubraca® (rucaparib) Achieves Primary Endpoint in Men with Metastatic Castration-Resistant Prostate Cancer with BRCA or ATM Mutations	NASDAQ:CLVS	Clovis Oncology Inc
2022/09/21	21:00	Business Wire	Clovis Oncology and Isotopia Announce Lutetium-177 Clinical Supply Agreement	NASDAQ:CLVS	Clovis Oncology Inc
2022/09/13	21:00	Business Wire	Clovis Oncology Submits Applications for Rubraca® Label Expansion in the US and European Union as First-line Maintenance Treatment in Women with Advanced Ovarian Cancer	NASDAQ:CLVS	Clovis Oncology Inc
2022/09/12	20:55	TipRanks	Clovis (NASDAQ:CLVS) Jumps After Rubraca Shows Progression-Free Survival in Ovarian Cancer	NASDAQ:CLVS	Clovis Oncology Inc
2022/09/11	23:30	Business Wire	Clovis Oncology’s Rubraca® (Rucaparib) as First-Line Maintenance Treatment Improves Progression-Free Survival in Women with Advanced Ovarian Cancer Across Disease Risk Subgroups	NASDAQ:CLVS	Clovis Oncology Inc
2022/09/07	05:16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CLVS	Clovis Oncology Inc
2022/09/07	05:16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CLVS	Clovis Oncology Inc